Detection of tumor cell-specific mRNA in the peripheral blood of patients with breast cancer-evaluation of several markers with real-time reverse transcription-PCR

International Journal of Molecular Sciences

Volumn 14, Issue 1, 2013, Pages 1093-1104

  Andergassen, Ulrich ^a   Hofmann, Simone ^a   Kölbl, Alexandra C ^a   Schindlbeck, Christian ^b   Neugebauer, Julia ^a   Hutter, Stefan ^a   Engelstädter, Verena ^a   Ilmer, Matthias ^c   Friese, Klaus ^a   Jeschke, Udo ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Klinikum Traunstein   (Germany)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Breast cancer; Circulating tumor cells; Marker genes; Reverse transcription real time PCR

Indexed keywords

CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 8; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MAMMAGLOBIN; MESSENGER RNA; GAMMA SYNUCLEIN; KERATIN; MAMMAGLOBIN A; SNCG PROTEIN, HUMAN; TUMOR MARKER; TUMOR PROTEIN;

ARTICLE; BLOOD SAMPLING; BREAST CANCER; BREAST CANCER SPECIFIC GENE; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKERATIN 18 GENE; CYTOKERATIN 19 GENE; CYTOKERATIN 8 GENE; GENE EXPRESSION; HER2 GENE; HUMAN; HUMAN CELL; MAMMAGLOBIN GENE; MARKER GENE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TUMOR GENE; BLOOD; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METASTASIS; PROCEDURES; PROGNOSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TUMOR EMBOLISM;

BIOMARKERS, TUMOR; BREAST NEOPLASMS; FEMALE; GAMMA-SYNUCLEIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KERATIN-18; KERATIN-19; KERATIN-8; KERATINS; MAMMAGLOBIN A; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; RECEPTOR, ERBB-2; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY;

EID: 84872183388     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms14011093     Document Type: Article

References (46)

1. Zhang, L.; Zhou, W.; Velculescu, V.E.; Kern, S.E.; Hruban, R.H.; Hamilton, S.R.; Vogelstein, B.; Kinzler, K.W. Gene expression profiles in normal and cancer cells. Science 1997, 276, 1268-1272.
2. Frasor, J.; Danes, J.M.; Komm, B.; Chang, K.C.; Lyttle, C.R.; Katzenellenbogen, B.S. Profiling of estrogen up-and down-regulated gene expression in human breast cancer cells: Insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 2003, 144, 4562-4574.
3. Hedenfalk, I.; Duggan, D.; Chen, Y.; Radmacher, M.; Bittner, M.; Simon, R.; Meltzer, P.; Gusterson, B.; Esteller, M.; Kallioniemi, O.P.; et al. Gene-expression profiles in hereditary breast cancer. N. Engl. J. Med. 2001, 344, 539-548.
4. Pantel, K.; Brakenhoff, R.H. Dissecting the metastatic cascade. Nat. Rev. Cancer 2004, 4, 448-456.
5. Ring, A.; Smith, I.E.; Dowsett, M. Circulating tumour cells in breast cancer. Lancet Oncol. 2004, 5, 79-88.
6. Smerage, J.B.; Hayes, D.F. The measurement and therapeutic implications of circulating tumour cells in breast cancer. Br. J. Cancer 2006, 94, 8-12.
7. Braun, S.; Pantel, K.; Muller, P.; Janni, W.; Hepp, F.; Kentenich, C.R.; Gastroph, S.; Wischnik, A.; Dimpfl, T.; Kindermann, G.; et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N. Engl. J. Med. 2000, 342, 525-533.
8. Braun, S.; Vogl, F.D.; Naume, B.; Janni, W.; Osborne, M.P.; Coombes, R.C.; Schlimok, G.; Diel, I.J.; Gerber, B.; Gebauer, G.; et al. A pooled analysis of bone marrow micrometastasis in breast cancer. N. Engl. J. Med. 2005, 353, 793-802.
9. Kurec, A.S.; Baltrucki, L.; Mason, D.Y.; Davey, F.R. Use of the APAAP method in the classification and diagnosis of hematologic disorders. Clin. Lab Med. 1988, 8, 223-236.
10. Noack, F.; Schmitt, M.; Bauer, J.; Helmecke, D.; Kruger, W.; Thorban, S.; Sandherr, M.; Kuhn, W.; Graeff, H.; Harbeck, N. A new approach to phenotyping disseminated tumor cells: Methodological advances and clinical implications. Int. J. Biol. Markers 2000, 15, 100-104.
11. Fleming, T.P.; Watson, M.A. Mammaglobin, a breast-specific gene, and its utility as a marker for breast cancer. Ann. N. Y. Acad. Sci. 2000, 923, 78-89.
12. Inaba, S.; Li, C.; Shi, Y.E.; Song, D.Q.; Jiang, J.D.; Liu, J. Synuclein gamma inhibits the mitotic checkpoint function and promotes chromosomal instability of breast cancer cells. Breast Cancer Res. Treat. 2005, 94, 25-35.
13. Jiang, Y.; Liu, Y.E.; Goldberg, I.D.; Shi, Y.E. Gamma synuclein, a novel heat-shock protein-associated chaperone, stimulates ligand-dependent estrogen receptor alpha signaling and mammary tumorigenesis. Cancer Res. 2004, 64, 4539-4546.
14. Wu, K.; Quan, Z.; Weng, Z.; Li, F.; Zhang, Y.; Yao, X.; Chen, Y.; Budman, D.; Goldberg, I.D.; Shi, Y.E. Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis. Breast Cancer Res. Treat. 2007, 101, 259-267.
15. Wu, K.; Weng, Z.; Tao, Q.; Lin, G.; Wu, X.; Qian, H.; Zhang, Y.; Ding, X.; Jiang, Y.; Shi, Y.E. Stage-specific expression of breast cancer-specific gene gamma-synuclein. Cancer Epidemiol. Biomarkers Prev. 2003, 12, 920-925.
16. Guo, J.; Shou, C.; Meng, L.; Jiang, B.; Dong, B.; Yao, L.; Xie, Y.; Zhang, J.; Chen, Y.; Budman, D.R.; et al. Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer. Int. J. Cancer 2007, 121, 1296-1305.
17. Pan, Z.Z.; Bruening, W.; Giasson, B.I.; Lee, V.M.; Godwin, A.K. Gamma-synuclein promotes cancer cell survival and inhibits stress-and chemotherapy drug-induced apoptosis by modulating MAPK pathways. J. Biol. Chem. 2002, 277, 35050-35060.
18. Giani, C.; Casalini, P.; Pupa, S.M.; De Vecchi, R.; Ardini, E.; Colnaghi, M.I.; Giordano, A.; Menard, S. Increased expression of c-erbB-2 in hormone-dependent breast cancer cells inhibits cell growth and induces differentiation. Oncogene 1998, 17, 425-432.
19. Kim, Y.S.; Konoplev, S.N.; Montemurro, F.; Hoy, E.; Smith, T.L.; Rondon, G.; Champlin, R.E.; Sahin, A.A.; Ueno, N.T. HER-2/neu overexpression as a poor prognostic factor for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous stem cell transplantation. Clin. Cancer Res. 2001, 7, 4008-4012.
20. Slamon, D.J.; Clark, G.M.; Wong, S.G.; Levin, W.J.; Ullrich, A.; McGuire, W.L. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987, 235, 177-182.
21. Konecny, G.E.; Thomssen, C.; Luck, H.J.; Untch, M.; Wang, H.J.; Kuhn, W.; Eidtmann, H.; du Bois, A.; Olbricht, S.; Steinfeld, D.; et al. Her-2/neu gene amplification and response to paclitaxel in patients with metastatic breast cancer. J. Natl. Cancer Inst. 2004, 96, 1141-1151.
22. Moliterni, A.; Menard, S.; Valagussa, P.; Biganzoli, E.; Boracchi, P.; Balsari, A.; Casalini, P.; Tomasic, G.; Marubini, E.; Pilotti, S.; et al. HER2 overexpression and doxorubicin in adjuvant chemotherapy for resectable breast cancer. J. Clin. Oncol. 2003, 21, 458-462.
23. Tai, W.; Mahato, R.; Cheng, K. The role of HER2 in cancer therapy and targeted drug delivery. J. Controlled Release 2010, 146, 264-275.
24. Bergqvist, J.; Ohd, J.F.; Smeds, J.; Klaar, S.; Isola, J.; Nordgren, H.; Elmberger, G.P.; Hellborg, H.; Bjohle, J.; Borg, A.L.; et al. Quantitative real-time PCR analysis and microarray-based RNA expression of HER2 in relation to outcome. Ann. Oncol. 2007, 18, 845-850.
25. Mendoza, G.; Portillo, A.; Olmos-Soto, J. Accurate breast cancer diagnosis through real-time PCR her-2 gene quantification usin immunohistochemically-identified biopsies. Oncol. Lett. 2013, 5, 295-298.
26. Bernard, P.S.; Wittwer, C.T. Real-time PCR technology for cancer diagnostics. Clin. Chem. 2002, 48, 1178-1185.
27. Krawczyk, N.; Banys, M.; Neubauer, H.; Solomayer, E.F.; Gall, C.; Hahn, M.; Becker, S.; Bachmann, R.; Wallwiener, D.; Fehm, T. HER2 status on persistent disseminated tumor cells after adjuvant therapy may differ from initial HER2 status on primary tumor. Anticancer Res. 2009, 29, 4019-4024.
28. Solomayer, E.F.; Becker, S.; Pergola-Becker, G.; Bachmann, R.; Kramer, B.; Vogel, U.; Neubauer, H.; Wallwiener, D.; Huober, J.; Fehm, T.N. Comparison of HER2 status between primary tumor and disseminated tumor cells in primary breast cancer patients. Breast Cancer Res. Treat. 2006, 98, 179-184.
29. Balbin, M.; Pendas, A.M.; Uria, J.A.; Jimenez, M.G.; Freije, J.P.; Lopez-Otin, C. Expression and regulation of collagenase-3 (MMP-13) in human malignant tumors. APMIS 1999, 107, 45-53.
30. Chang, H.J.; Yang, M.J.; Yang, Y.H.; Hou, M.F.; Hsueh, E.J.; Lin, S.R. MMP13 is potentially a new tumor marker for breast cancer diagnosis. Oncol. Rep. 2009, 22, 1119-1127.
31. Lafleur, M.A.; Drew, A.F.; de Sousa, E.L.; Blick, T.; Bills, M.; Walker, E.C.; Williams, E.D.; Waltham, M.; Thompson, E.W. Upregulation of matrix metalloproteinases (MMPs) in breast cancer xenografts: A major induction of stromal MMP-13. Int. J. Cancer 2005, 114, 544-554.
32. Selvamurugan, N.; Partridge, N.C. Constitutive expression and regulation of collagenase-3 in human breast cancer cells. Mol. Cell Biol. Res. Commun. 2000, 3, 218-223.
33. Nikseresht, M.; Seghatoleslam, A.; Monabati, A.; Talei, A.; Ghalati, F.B.; Owji, A.A. Overexpression of the novel human gene, UBE2Q2, in breast cancer. Cancer Genet. Cytogenet 2010, 197, 101-106.
34. Fabre-Lafay, S.; Garrido-Urbani, S.; Reymond, N.; Goncalves, A.; Dubreuil, P.; Lopez, M. Nectin-4, a new serological breast cancer marker, is a substrate for tumor necrosis factor-alpha-converting enzyme (TACE)/ADAM-17. J. Biol. Chem. 2005, 280, 19543-19550.
35. Dontu, G. Breast cancer stem cell markers-The rocky road to clinical applications. Breast Cancer Res. 2008, 10, 110.
36. De Cremoux, P.; Tran-Perennou, C.; Brockdorff, B.L.; Boudou, E.; Brunner, N.; Magdelenat, H.; Lykkesfeldt, A.E. Validation of real-time RT-PCR for analysis of human breast cancer cell lines resistant or sensitive to treatment with antiestrogens. Endocr. Relat. Cancer 2003, 10, 409-418.
37. Mitas, M.; Mikhitarian, K.; Walters, C.; Baron, P.L.; Elliott, B.M.; Brothers, T.E.; Robison, J.G.; Metcalf, J.S.; Palesch, Y.Y.; Zhang, Z.; et al. Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel. Int. J. Cancer 2001, 93, 162-171.
38. Weissenstein, U.; Schumann, A.; Reif, M.; Link, S.; Toffol-Schmidt, U.D.; Heusser, P. Detection of circulating tumor cells in blood of metastatic breast cancer patients using a combination of cytokeratin and EpCAM antibodies. BMC Cancer 2012, 12, 206.
39. Alix-Panabieres, C. EPISPOT assay: Detection of viable DTCs/CTCs in solid tumor patients. Recent Results Cancer Res. 2012, 195, 69-76.
40. Wang, N.; Shi, L.; Li, H.; Hu, Y.; Du, W.; Liu, W.; Zheng, J.; Huang, S.; Qu, X. Detection of circulating tumor cells and tumor stem cells in patients with breast cancer by using flow cytometry: A valuable tool for diagnosis and prognosis evaluation. Tumour Biol. 2012, 33, 561-569.
41. Markou, A.; Strati, A.; Malamos, N.; Georgoulias, V.; Lianidou, E.S. Molecular characterization of circulating tumor cells in breast cancer by a liquid bead array hybridization assay. Clin. Chem. 2011, 57, 421-430.
42. Dydensborg, A.B.; Herring, E.; Auclair, J.; Tremblay, E.; Beaulieu, J.F. Normalizing genes for quantitative RT-PCR in differentiating human intestinal epithelial cells and adenocarcinomas of the colon. Am. J. Physiol. 2006, 290, G1067-G1074.
43. Vandesompele, J.; De Preter, K.; Pattyn, F.; Poppe, B.; van Roy, N.; De Paepe, A.; Speleman, F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3, RESEARCH0034.
44. Livak, K.J.; Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) Method. Methods 2001, 25, 402-408.
45. Gervasoni, A.; Monasterio Munoz, R.M.; Wengler, G.S.; Rizzi, A.; Zaniboni, A.; Parolini, O. Molecular signature detection of circulating tumor cells using a panel of selected genes. Cancer Lett. 2008, 263, 267-279.
46. Bolke, E.; Orth, K.; Gerber, P.A.; Lammering, G.; Mota, R.; Peiper, M.; Matuschek, C.; Budach, W.; Rusnak, E.; Shaikh, S.; et al. Gene expression of circulating tumour cells in breast cancer patients. Eur. J. Med. Res. 2009, 14, 426-432.